Traws Pharma Inc [NASDAQ: TRAW] price surged by 150.40 percent to reach at $7.55.
The one-year TRAW stock forecast points to a potential downside of -109.5. The average equity rating for TRAW stock is currently 1.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guru’s Opinion on Traws Pharma Inc [TRAW]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TRAW shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TRAW stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Traws Pharma Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 01, 2022. While these analysts kept the previous recommendation, Guggenheim raised their target price to Buy. The new note on the price target was released on May 18, 2021, representing the official price target for Traws Pharma Inc stock. Previously, the target price had yet another raise from $6 to $7.50, while H.C. Wainwright kept a Buy rating on TRAW stock.
The Average True Range (ATR) for Traws Pharma Inc is set at 1.38, with the Price to Sales ratio for TRAW stock in the period of the last 12 months amounting to 155.62.
TRAW Stock Performance Analysis:
Traws Pharma Inc [TRAW] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 167.58. With this latest performance, TRAW shares gained by 178.71% in over the last four-week period, additionally plugging by 16.39% over the last 6 months – not to mention a rise of 43.27% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TRAW stock in for the last two-week period is set at 87.38, with the RSI for the last a single of trading hit 91.46, and the three-weeks RSI is set at 82.80 for Traws Pharma Inc [TRAW]. The present Moving Average for the last 50 days of trading for this stock 5.11, while it was recorded at 6.64 for the last single week of trading, and 11.07 for the last 200 days.
Insight into Traws Pharma Inc Fundamentals:
Traws Pharma Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.07 and a Current Ratio set at 1.07.
